Empower Your Health Journey

  Why Is Pancreatic Cancer So Difficult to Treat — and Where Is the Hope? Over the past several decades, advances in medicine, surgery, targeted therapy, and immunotherapy have dramatically improved survival rates for many cancers. Yet pancreatic cancer remains one of the deadliest malignancies. Despite years of research, the prognosis for pancreatic cancer patients is still poor compared with many other tumor types. In the United States, pancreatic cancer consistently ranks among the leading causes of cancer-related death, even though it is not among the most common cancers. Why has pancreatic cancer been so difficult to defeat? And where does the hope for future breakthroughs lie? Scientists generally believe that three major biological challenges are responsible: 1. Pancreatic cancer is extremely difficult to detect early 2. There has long been a lack of effective targeted therapies 3. The tumor microenvironment forms a powerful protective barrier At the same time,...

  For many people, surgery has long been viewed as the essential step in curing cancer. The common belief is simple: if the tumor can be removed, there is hope for a cure. However, advances in modern cancer therapy are beginning to challenge this traditional view. With the rapid development of neoadjuvant therapy — treatment given before surgery — some breast cancer patients are achieving remarkable responses. In certain cases, tumors completely disappear after drug treatment alone, raising an important question: If no cancer can be found, is surgery always necessary? A recent study led by MD Anderson Cancer Center explored this possibility in patients with early-stage breast cancer. The study focused on patients with triple-negative breast cancer or HER2-positive breast cancer who had undergone standard neoadjuvant therapy. After treatment, researchers performed image-guided needle biopsies of both the original tumor site and surrounding lymph nodes. Among the 50 patients en...